UTHR
United Therapeutics Corporation Earnings
$445.95
Earnings Summary
Revenue | $799.5Mn |
Net Profits | $338.7Mn |
Net Profit Margins | 42.36% |
United Therapeutics Corporation’s revenue jumped 6.76% since last year same period to $799.5Mn in the Q3 2025. On a quarterly growth basis, United Therapeutics Corporation has generated 0.11% jump in its revenue since last 3-months.
United Therapeutics Corporation’s net profit jumped 9.58% since last year same period to $338.7Mn in the Q3 2025. On a quarterly growth basis, United Therapeutics Corporation has generated 9.43% jump in its net profits since last 3-months.
United Therapeutics Corporation’s net profit margin jumped 2.64% since last year same period to 42.36% in the Q3 2025. On a quarterly growth basis, United Therapeutics Corporation has generated 9.31% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 7.31 |
EPS Estimate Current Year | 7.31 |
United Therapeutics Corporation’s earning per share (EPS) estimates for the current quarter stand at 7.31 - a -0.54% fall from last quarter’s estimates.
United Therapeutics Corporation’s earning per share (EPS) estimates for the current year stand at 7.31.
Key Ratios
Earning Per Share (EPS) | 0 |
United Therapeutics Corporation’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the United Therapeutics Corporation has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-04-30 | 6.66 | 6.63 | -0.46% |
2025-10-29 | 7.31 | 0 | -100% |
2025-07-30 | 7.35 | 6.41 | -12.79% |
